Critical issues in drug and biomarker development and standardisation of assays
7 Jan 2021
Critical issues in drug and biomarker development and standardisation of assays
Geographic disparities in access to cancer clinical trials in India
Latest in non-small cell lung cancer pathology
The Burkitt lymphoma international prognostic index
Guidelines to ensure high quality palliative care
The use of PARP inhibitors in oncology from a palliative care perspective
Cyber knife radiation for prostate cancer
An overview of the London Global Cancer Week
OncoAlert Colloquium Day 5: Genitourinary tumours and social media
OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma
OncoAlert Colloquium Day 3: Breast cancer
OncoAlert Colloquium Day 2: Lung cancer and SIOG